Amdocs Limited (NASDAQ:DOX) Receives Average Recommendation of “Hold” from Analysts

Shares of Amdocs Limited (NASDAQ:DOX) have been assigned an average recommendation of “Hold” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $74.83.

DOX has been the topic of several research reports. Citigroup cut their price target on shares of Amdocs from $83.00 to $76.00 and set a “buy” rating on the stock in a report on Monday, May 11th. ValuEngine downgraded shares of Amdocs from a “hold” rating to a “sell” rating in a report on Thursday. TheStreet upgraded shares of Amdocs from a “c+” rating to a “b-” rating in a report on Friday, May 15th. Finally, BidaskClub downgraded shares of Amdocs from a “hold” rating to a “sell” rating in a report on Tuesday, June 23rd.

Hedge funds have recently made changes to their positions in the business. Rockefeller Capital Management L.P. lifted its holdings in Amdocs by 138.4% in the 4th quarter. Rockefeller Capital Management L.P. now owns 391 shares of the technology company’s stock valued at $28,000 after purchasing an additional 227 shares in the last quarter. WASHINGTON TRUST Co acquired a new stake in shares of Amdocs in the 1st quarter worth $29,000. CWM Advisors LLC acquired a new stake in shares of Amdocs in the 1st quarter worth $44,000. RMR Wealth Builders acquired a new stake in shares of Amdocs in the 4th quarter worth $50,000. Finally, CFM Wealth Partners LLC acquired a new stake in shares of Amdocs in the 1st quarter worth $53,000. Institutional investors own 90.72% of the company’s stock.

Shares of DOX traded down $1.08 during mid-day trading on Friday, hitting $60.02. 953,416 shares of the company traded hands, compared to its average volume of 959,858. Amdocs has a 1-year low of $44.05 and a 1-year high of $77.29. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $8.09 billion, a PE ratio of 16.44, a price-to-earnings-growth ratio of 1.73 and a beta of 0.69. The business has a 50 day moving average of $62.07 and a 200 day moving average of $65.13.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Thursday, May 7th. The technology company reported $1.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.06 by $0.02. Amdocs had a net margin of 11.98% and a return on equity of 16.03%. The firm had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the prior year, the company posted $1.06 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, research analysts expect that Amdocs will post 4.08 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 24th. Shareholders of record on Tuesday, June 30th will be issued a $0.327 dividend. The ex-dividend date is Monday, June 29th. This represents a $1.31 dividend on an annualized basis and a yield of 2.18%. Amdocs’s payout ratio is currently 32.19%.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

Further Reading: What does a bar chart mean for investors?

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.